37
Views
3
CrossRef citations to date
0
Altmetric
Review

21st Century treatment of diabetic retinopathy

, &
Pages 623-631 | Published online: 10 Jan 2014
 

Abstract

Despite marked improvements in the treatment of diabetes and its retinal complications, diabetic retinopathy remains a leading cause of blindness and vision impairment in working-age adults. Control of blood glucose and blood pressure will remain important means to prevent the onset and progression of diabetic retinopathy. Current and improved surgical treatments, such as laser therapy and vitrectomy, have also proved highly effective in preventing major visual loss in advanced stages of retinopathy. In this review, emerging drug-based therapies (corticosteroids, somatostatin analogues, anti-VEGF agents, a specific PKCβ1/2 inhibitor [ruboxistaurin]), more effective inhibitors of aldose reductase, inhibitors of the renin–angiotensin system and anti-inflammatory agents that could help to preserve sight in the growing population of diabetic patients into the 21st Century are discussed.

Financial disclosure

The authors have no relevant financial interests related to this manuscript, including employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 608.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.